Tilray | TRLY - 营业费用

股票价格

8.54

每天变化

-0.58 -6.36%

每月一次

-17.57%

每年

818.28%

Q1 预测

9.24

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 6.75B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	营业费用	更改		日
Acasti Pharma	USD 62.82M		59.73M	2025-09
Akebia Therapeutics	USD 63.08M		8.26M	2025-12
Alaunos Therapeutics	USD 1.19M		148K	2025-09
Aurora Cannabis	CAD 129.98M		16.05M	2025-12
Avita Medical	AUD 28.02M		1.55M	2025-12
Canopy Growth	CAD 87.2M		6.22M	2025-12
Cronos Group	USD 51.59M		70.5M	2025-12
Dianthus Therapeutics	USD 69.82M		29.14M	2025-12
Divis Laboratories Ltd	INR 18.32B		1.08B	2025-12
Ionis Pharmaceuticals	USD 418M		101.1M	2025-12
IQVIA Holdings	USD 1.69B		4.47B	2025-12
Knight Therapeutics	CAD 126.9M		8.29M	2025-12
Moderna	USD 1.54B		259M	2025-12
Organigram Holdings	CAD 83.66M		24.44M	2025-12
Organon & Co	USD 906M		362M	2025-09
Revvity	USD 626.22M		25.62M	2025-12
Tectonic Therapeutic	USD 21.52M		374K	2025-12
Tilray	USD 237.52M		17.34M	2025-09
Viatris	USD 3.86B		335.7M	2025-12
Xeris Pharmaceuticals	USD 69.03M		1.38M	2025-12
Zealand Pharma A/S	775.97M		265.08M	2025-12